Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Quality Improvement Plan for Hypertension Control (INCOTECA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00820183
Recruitment Status : Completed
First Posted : January 12, 2009
Last Update Posted : May 7, 2009
Sponsor:
Information provided by:
Jordi Gol i Gurina Foundation

Study Description
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
The study hypothesis is that the implementation of a plan for quality improvement at the primary care health teams taking care of hypertensive patients, will increase the level of blood pressure control among those patients.

Condition or disease Intervention/treatment Phase
Hypertension Other: Quality Improvement plan for Hypertension Control Not Applicable

Detailed Description:

The study is to compare the results on the hypertension control between two groups of primary health care teams. The intervention group will undertake a quality improvement plan for hypertension control, in which the following aspects will be included in the intervention:

Specific training programme on how to diagnose hypertension , and measure blood pressure correctly To send feed back information to primary care health professionals about poorly controlled hypertensive patients An audit will be performed, every 6 months, to see the adhesion to the recommended clinical guidelines , and the information will be diffused among the participant primary health care professionals Each participant primary health care team will have a designated reference person, that will provide support on any doubts on the programme implementation.

The non intervention group will follow hypertensive patients following the same clinical practice guide as the intervention group, with no intervention on the primary health care professionals

Study Design
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 34327 participants
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: Single (Participant)
Primary Purpose: Health Services Research
Official Title: A Quality Improvement Plan for Hypertension Control: the INCOTECA Project
Study Start Date : February 2006
Actual Primary Completion Date : April 2007
Actual Study Completion Date : April 2008

Resource links provided by the National Library of Medicine


Arms and Interventions
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Arm Intervention/treatment
Experimental: quality improvement plan
It will be the group of primary health care teams who will undertake the quality improvement plan for hypertensive patients
 Other: Quality Improvement plan for Hypertension Control

Implementation of a plan of quality improvement addressed to health professionals in Primary Health Care Teams. It includes:

Specific training programme on how to diagnose hypertension , and measure blood pressure correctly To send feed back information to primary care health professionals about poorly controlled hypertensive patients An audit will be performed, every 6 months, to see the adhesion to the recommended clinical guidelines , and the information will be diffused among the participant primary health care professionals Each participant primary health care team will have a designated reference person, that will provide support on any doubts on the programme implementation
No Intervention: non intervention
It will be the group of primary health care teams that will not undertake the quality improvement plan for hypertension control


Outcome Measures
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. good control of hypertension as a dichotomous variable, based on systolic blood pressure and diastolic blood pressure records over the last 12 months [ Time Frame: every three months, for a whole year ]

Secondary Outcome Measures :
  1. treatment with antihypertensive drugs, number of antihypertensive drugs, assessment of therapeutic compliance [ Time Frame: every three months, for a whole year ]

Eligibility Criteria
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients diagnosed with hypertension before January 1st, 2006
  • Patients assigned at the primary health team participating, and with clinical electronic records

Exclusion Criteria:

  • Patients diagnosed with hypertension after January 1st, 2006
  • Patients under 18 years of age
  • Patients with a diastolic blood pressure higher than systolic blood pressure as recorded in the clinical records
Contacts and Locations
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00820183


Locations
Layout table for location information
Spain
SAP Cerdanyola-Ripollet Institut Català de la Salut
Cerdanyola del Vallès, Barcelona, Spain
Sponsors and Collaborators
Jordi Gol i Gurina Foundation
Investigators
Layout table for investigator information
Principal Investigator: Roser Valles Fernandez Institut Català de la Salut
More Information
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Additional Information:

Layout table for additonal information
Responsible Party: Roser VallésFernández, Institut Català de la Salut
ClinicalTrials.gov Identifier: NCT00820183    
Other Study ID Numbers: RSB_2006
First Posted: January 12, 2009    Key Record Dates
Last Update Posted: May 7, 2009
Last Verified: January 2009
Keywords provided by Jordi Gol i Gurina Foundation:
Hypertension
Intervention
Primary Care
Quality improvement
Additional relevant MeSH terms:
Layout table for MeSH terms
Hypertension
Vascular Diseases
Cardiovascular Diseases